SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-09-007552
Filing Date
2009-01-16
Accepted
2009-01-16 16:14:10
Documents
6
Period of Report
2009-01-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 24513
2 UNDERWRITING AGREEMENT dex11.htm EX-1.1 134373
3 OFFICERS' CERTIFICATE OF AMGEN INC. dex42.htm EX-4.2 125122
4 OPINION OF LATHAM & WATKINS LLP dex51.htm EX-5.1 16673
5 GRAPHIC g76984g27y99.jpg GRAPHIC 2447
6 GRAPHIC g76984g63u10.jpg GRAPHIC 1917
  Complete submission text file 0001193125-09-007552.txt   308627
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-12477 | Film No.: 09531703
SIC: 2836 Biological Products, (No Diagnostic Substances)